CCC3 , also known under the name CarboHealth, started in 2013 and runs through to the end of 2017. CCC CarboHealth (CCC3) aims to develop a toolbox to support the European Food Safety Authority (EFSA) in substantiating health claims regarding dietary fibre. CarboHealth is conducting fundamental and demand-driven research on the effects of known and potential new prebiotics on human intestinal flora.
Knowledge institutes and businesses have joined hands in CCC CarboHealth (CCC3) to stimulate and dig deeper into knowledge on the role of starches and carbohydrates in health. The aim is to make meaningful contributions to healthier societies and to subjects like Healthy Ageing, but while doing so also generating added value for CCC partners. CCC CarboHealth (CCC3) has a program volume of €3.3 million, €1.7 million of which is private investment (cash and in-kind).
Six business enterprises are participating in the consortium – FrieslandCampina, AVEBE, Sensus, Nutreco, Winclove and Danone Nutricia – alongside four knowledge institutes – WUR, UG, UMCG and DLO-FBR.